What conditions does InventisBio Co., Ltd run trials for?

In our tracked recruiting trials, InventisBio Co., Ltd sponsors trials for Psoriasis, Plaque Psoriasis, Active Systemic Lupus Erythematosus.

Clinical trials sponsored by InventisBio Co., Ltd

Recruiting trials

Conditions studied

Phase 2 3Phase 3 3

Condition	Trials
Psoriasis	4
Plaque Psoriasis	2
Active Systemic Lupus Erythematosus	1
Breast Cancer	1
Lupus	1
PsA (Psoriatic Arthritis)	1

A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis
NCT07326813 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis
NCT07315061 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE)
NCT07311200 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer
NCT06954961 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: Female · 2 locations
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
NCT07489885 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 20 locations
Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis
NCT07130604 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location